Rani Therapeutics Holdings, Inc. (RANI)

RANI Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.64	18.62	3.76	5.86	27.01	117.45
Short-Term Investments	33.76	31.09	23.88	42.68	71.48	-
Cash & Short-Term Investments	43.4	49.71	27.64	48.54	98.48	117.45
Cash Growth	173.78%	79.85%	-43.06%	-50.71%	-16.15%	60.77%
Accounts Receivable	2.04	2.04	-	-	-	-
Other Receivables	-	-	0.43	-	-	-
Total Trade Receivables	2.04	2.04	0.43	-	-	-
Other Current Assets	1.65	1.57	1.68	2.31	2.44	2.14
Total Current Assets	47.09	53.32	29.74	50.85	100.92	119.6
Net Property, Plant & Equipment	4.54	5.05	6.64	6.82	7.1	4.61
Other Long-Term Assets	0.25	0.25	0.25	0.25	-	-
Total Assets	51.88	58.62	36.63	57.92	108.03	124.21

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	0.86	0.31	1.36	0.65	1.46	1.08
Accrued Expenses	4.71	3.94	2.07	1.73	2.35	1.56
Current Portion of Long-Term Debt	-	-	15	4.9	-	-
Current Portion of Leases	1.46	1.59	1.46	0.72	1.01	-
Unearned Revenue	6.83	6.83	-	-	-	-
Total Current Liabilities	13.86	12.67	19.89	7.99	4.82	2.64
Long-Term Debt	-	-	9.61	24.48	29.15	-
Long-Term Leases	2.48	2.73	3.64	-	0.06	-
Other Long-Term Liabilities	-	1.71	-	-	-	-
Total Long-Term Liabilities	2.48	4.44	13.25	24.48	29.21	-
Total Liabilities	16.34	17.11	33.14	32.47	34.02	2.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	168.02	165.58	104.89	85.76	75.84	55.74
Accumulated Other Comprehensive Income	-0.01	0	0.01	-0.01	-0.07	-
Retained Earnings	-139.61	-132.58	-102.91	-72.89	-38.92	-8.33
Total Common Shareholders' Equity	28.41	33.01	1.99	12.87	36.86	47.41
Minority Interest	7.14	8.5	1.5	12.58	37.15	74.16
Shareholders' Equity	35.54	41.51	3.49	25.44	74	121.57
Total Liabilities & Equity	51.88	58.62	36.63	57.92	108.03	124.21

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	3.94	4.32	29.71	30.1	30.21	0
Net Cash (Debt)	39.46	45.39	-2.07	18.44	68.27	117.45
Net Cash Growth	-	-	-	-72.99%	-41.88%	69.52%
Net Cash Per Share	0.39	0.69	-0.07	0.72	2.87	6.01
Book Value	28.41	33.01	1.99	12.87	36.86	47.41
Book Value Per Share	0.28	0.50	0.07	0.50	1.55	2.43
Tangible Book Value	28.41	33.01	1.99	12.87	36.86	47.41
Tangible Book Value Per Share	0.28	0.50	0.07	0.50	1.55	2.43

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 29, 2026

Data Sources Report a data error